CXCL12 can be degraded and inactivated by a surface enzyme, DPP4/CD26 [145], which is expressed by basophil-like CML cells [127] as well as CML LSCs [85]. Here, CXCL12 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.